Bleomycin combined with Interleukin-2 in the treatment of patients with malignant pleural effusion from NSCLC / 肿瘤研究与临床

ABSTRACT

Objective To evaluate the efficacy and adverse effects of bleomycin combined with Interleukin-2 for malignant pleural effusions in patients with NSCLC. Methods Malignant pleural effusions were excreted cleanly from indwelling chest tube, bleomycin and Interleukin-2 were injected thorax. Results Total survival rate is 88.5 %, only part patients have fever, chest pain, tetter, nausea. Conclusion Bleomycin combined with Interleukin-2 treat patients with malignant pleural effusion from NSCLC, the efficacy are better, the adverse effects are tolerabe.